Therapeutic agent for glaucoma containing adenosine derivative as active ingredient
Details for Australian Patent Application No. 2008241496 (hide)
International Classifications
Event Publications
3 December 2009 PCT application entered the National Phase
PCT publication WO2008/130520 Priority application(s): WO2008/130520
3 May 2012 Assignment before Grant
Santen Pharmaceutical Co., Ltd.; PGxHealth, LLC The application has been assigned to Forest Laboratories Holdings Limited; Santen Pharmaceutical Co., Ltd.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008241500-Aryl heterocyclic CGRP receptor antagonists
2008241490-Substituted biphenyl phenoxy-, thiophenyland aminophenylpropanoic acid GPR40 modulators
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser